MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia

Oncogene

Volumn 17, Issue 21, 1998, Pages 2711-2717

  Daphna Iken, D ^a   Shankar, D B ^b   Lawshe A ^a   Ornitz, D M ^a   Shackleford, G M ^b   MacArthur, C A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast cancer; Fgf8; FGF8; Fibroblast growth factor; Mammary tumorigenesis; Oncogenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; LUNG METASTASIS; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NORTHERN BLOTTING; OVARY HYPERTROPHY; PRIORITY JOURNAL; PROMOTER REGION; SALIVARY GLAND; SALIVARY GLAND TUMOR; TRANSGENIC MOUSE;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; TUMOR VIRUS;

EID: 0032569783     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202212     Document Type: Article

References (47)

1. Bansal GS, Cox HC, Marsh S, Gomm J, Yiangou C, Luqmani Y, Coombes RC and Johnston CL. (1997). Br. J. Cancer, 15, 1567-1574.
2. Basilico C and Moscatelli D. (1992). Adv. Cancer Res., 59, 115-165.
3. Blunt AG, Lawshé A, Cunningham ML, Seto ML, Ornitz DM and MacArthur CA. (1997). J. Biol. Chem., 272, 3733-3738.
4. Chomezynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
5. Coleman-Krnacik S and Rosen JM. (1994). Mol. Endocrino., 8, 218-29.
6. Crossley PH and Martin GR. (1995). Development. 121, 439-451.
7. Crossley PH, Martinez S and Martin GR. (1996a). Nature, 380, 66-68.
8. Crossley PH, Minowada G, MacArthur CA and Martin GR. (1996b). Cell, 84, 127-136.
9. Dickson C, Smith R, Brookes S and Peters G. (1984). Cell, 37, 529-536.
10. Haraguchi S, Good RA, Engelman RW and Day NK. (1992). Int. J. Cancer. 52, 928-33.
11. Haraguchi S, Good RA, Engelman RW, Greene S and Day NK. (1997). Mol. Cell. Endocrinol., 129, 145-55.
12. Harris JR, Lippman ME, Veronesi U and Willett W. (1992a). New Engl. J. Med., 327, 319-328.
13. Harris JR, Lippman ME, Veronesi U and Willelt W. (1992b). New Engl. J. Med., 327, 473-480.
14. Heikinheimo M, Lawshé A, Shackleford GM, Wilson DB and MacArthur CA. (1994). Mech. Dev. 48, 129-138.
15. Imagawa W, Cunha GR, Young P and Nandi S. (1994). Biochem. Biopliyx. Rex. Comm., 204, 1165-1169.
16. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovitra P and Nevanlinna H. (1993). Int. J. Cancer. 54, 378-382.
17. Jacquemier J, Adelaide J. Parc P, Penault-Llorca F, Planche J, DeLapeyriere O and Birnbaum D. (1994). Int. J. Cancer. 59, 373-378.
18. Johnson DE and Williams LT. (1993). Adv. Cancer Res., 60, 1-41.
19. Kapoun AM and Shackleford GM. (1997). Oncogene, 14, 2985-2989.
20. Kitsberg DI and Leder P. (1996). Oncogene, 13, 2507-2515.
21. Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T and Sato B. (1994). Oncogene, 9, 455-462.
22. Kwan HC, Pecenka V, Tsukamoto AS, Parslow TG, Guzman R, Lin TP, Muller WJ, Lee FS, Leder P and Varmus HE. (1992). Mol. Cell Biol., 12, 147-154.
23. Le Ricousse S, Gouilleux F, Fortin D, Joulin V and Richard-Foy H. (1996). Proc. Natl. Acad. Sci. USA, 93, 5072-7.
24. Lee FS, Lane TF, Kuo A, Shackleford GM and Leder P. (1995). Proc. Natl. Acad. Sci. USA, 92, 2268-72.
25. MacArthur CA, Lawshé A, Shankar DB, Heikinheimo M and Shackleford GM. (1995a). Cell Growth Diff., 6, 817-825.
26. MacArthur CA, Lawshe A, Xu JS, Santos-Ocampo S, Heikinheimo M, Chellaiah AT and Ornitz DM. (1995b). Development. 121, 3603-3613.
27. MacArthur CA, Shankar DB and Shackleford GM. (1995c). J. Virol., 69, 2501-2507.
28. Mathieu M, Chatelain E, Ornitz D, Bresnick J, Mason I, Kiefer P and Dickson C. (1995). J. Biol. Chem., 270, 24197-24203.
29. Matsui Y, Halter SA, Holt JT, Hogan BL and Coffey RJ. (1990). Cell. 61, 1147-55.
30. McKeehan WL and Kan M. (1994). Mol. Reproduct. Dev., 39, 69-82.
31. Meyers EN, Lewandoski M and Martin GR. (1998). Nature Genet., 18, 136-141.
32. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D and Aaronson SA. (1991). Science. 251, 72-75.
33. Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P and Leder P. (1990). EMBO J., 9, 907-13.
34. Ohuchi H, Nakagawa T, Yamamoto A, Araga A, Ohata T, Ishimaru Y, Yoshioka H, Kuwana T, Nohno T, Yamasaki M, Itoh N and Noji S. (1997). Development. 124, 2235-2244.
35. Ornitz DM, Moreadith RW and Leder P. (1991). Proc. Natl. Acad. Sci. USA, 88, 698-702.
36. Ornitz DM, Xu JS, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao GX and Goldfarb M. (1996). J. Biol. Chem., 271, 15292-15297.
37. Payson RA, Wu J, Liu Y and Chiu IM. (1996). Oncogene. 13, 47-53.
38. Penault-Llorca F, Bertucci F, Adelaide J, Pare P, Coulier F, Jacquemier J, Birnbaum D and deLapeyriere O. (1995). Int. J. Cancer. 61, 170-176.
39. Peters G, Brookes S, Smith R, Placzek M and Dickson C. (1989). Proc. Natl. Acad. Sci. USA, 86, 5678-5682.
40. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, Taylor WG, Fortney E, Sakata H, Finch PW et al. (1995). Cell Biol. Int., 19, 399-411.
41. Shackleford GM, MacArthur CA, Kwan HC and Varmus HE. (1993). Proc. Natl. Acad. Sci., USA, 90, 740-744.
42. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K and Yoshida H. (1995). FEBS Letters. 363, 226-230.
43. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H and Matsumoto K. (1992). Proc. Natl. Acad. Sci., USA, 89, 8928-8932.
44. Ulich TR, Yi ES, Cardiff R, Yin SM, Bikhazi N, Biltz R, Morris CF and Pierce GF. (1994). Am. J. Pathol., 144, 862-868.
45. Wilkinson DG. (1992). In Situ hybridization a practical approach. IRL Press, Oxford.
46. Wu J, Payson RA, Lang JC and Chiu IM. (1997). J. Steroid Biocheni. Mol., Biol., 62, 1-10.
47. Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani YA, Shousha S, Coombes RC and Johnston CL. (1997). Br. J. Cancer, 75, 28-33.